This translocation of EGFR from cancer cells to liver cells can inhibit the action of miRNA-26a/b, activate hepatocyte growth factor (HGF), and promote liver metastasis of cancer cells (Zhang et al., 2017). The gene discussed is EGFR; the disease is cancer.